- -

Head-to-head comparison of 1 week versus 6 months CMR-derived infarct size for prediction of late events after STEMI

RiuNet: Repositorio Institucional de la Universidad Politécnica de Valencia

Compartir/Enviar a

Citas

Estadísticas

  • Estadisticas de Uso

Head-to-head comparison of 1 week versus 6 months CMR-derived infarct size for prediction of late events after STEMI

Mostrar el registro sencillo del ítem

Ficheros en el ítem

dc.contributor.author Husser, Oliver es_ES
dc.contributor.author Monmeneu Menadas, José Vicente es_ES
dc.contributor.author Bonanad, Clara es_ES
dc.contributor.author Gomez, Cristina es_ES
dc.contributor.author Chaustre, Fabian es_ES
dc.contributor.author Nuñez, Julio es_ES
dc.contributor.author López Lereu, María Pilar es_ES
dc.contributor.author Minana, Gema es_ES
dc.contributor.author Sanchis, Juan es_ES
dc.contributor.author Mainar, Luis es_ES
dc.contributor.author Ruiz, Vicente es_ES
dc.contributor.author Forteza, Maria J. es_ES
dc.contributor.author Trapero, Isabel es_ES
dc.contributor.author Moratal Pérez, David es_ES
dc.contributor.author Chorro, Francisco J. es_ES
dc.contributor.author Bodi, Vicente es_ES
dc.date.accessioned 2017-07-24T12:22:14Z
dc.date.available 2017-07-24T12:22:14Z
dc.date.issued 2013-10
dc.identifier.issn 1569-5794
dc.identifier.uri http://hdl.handle.net/10251/85657
dc.description.abstract Infarct size (IS) at 1 week after ST-elevation myocardial infarction (MI) diminishes during the first months. The incremental prognostic value of IS regression and of scar size (SS) at 6 months is unknown. We compared cardiovascular magnetic resonance (CMR)-derived IS at 1 week and SS at 6 months after MI for predicting late major adverse cardiac events (MACE). 250 patients underwent CMR at 1 week and 6 months after MI. IS and SS were determined as the extent of transmural late enhancement (in > 50 % of wall thickness, ETLE). During 163 weeks, 23 late MACE (cardiac death, MI or readmission for heart failure after the 6 months CMR) occurred. Patients with MACE had a larger IS at 1 week (6 [4-9] vs. 3 [1-5], p < .0001) and a larger SS at 6 months (5 [2-6] vs. 3 [1-5], p = .005) than those without MACE. Late MACE rates in IS > median were higher at 1 week (14 vs. 4 %, p = .007) and in SS > median at 6 months (12 vs. 5 %, p = .053). The C-statistic for predicting late MACE of CMR at 1 week and 6 months was comparable (.720 vs. .746, p = .1). Only ETLE at 1 week (HR 1.31 95 % CI [1.14-1.52], p < .0001, per segment) independently predicted late MACE. CMR-derived SS at 6 months does not offer prognostic value beyond IS at 1 week after MI. The strongest predictor of late MACE is ETLE at 1 week. es_ES
dc.description.sponsorship y This work was supported by the "Instituto de Salud Carlos III" (PI1102323 grant). O. Husser was supported by the "Regensburger Forschungsforderung in der Medizin (ReForM)". en_EN
dc.language Inglés es_ES
dc.publisher Springer Verlag (Germany) es_ES
dc.relation.ispartof International Journal of Cardiovascular Imaging es_ES
dc.rights Reserva de todos los derechos es_ES
dc.subject Cardiovascular magnetic resonance es_ES
dc.subject ST-elevation myocardial infarction es_ES
dc.subject Prognosis es_ES
dc.subject Late gadolinium enhancement imaging es_ES
dc.subject.classification TECNOLOGIA ELECTRONICA es_ES
dc.title Head-to-head comparison of 1 week versus 6 months CMR-derived infarct size for prediction of late events after STEMI es_ES
dc.type Artículo es_ES
dc.identifier.doi 10.1007/s10554-013-0239-1
dc.relation.projectID info:eu-repo/grantAgreement/MICINN//PI11%2F02323/ES/La metabolómica en el diagnóstico y el pronóstico de las enfermedades cardiovasculares. Una aproximación traslacional/ es_ES
dc.rights.accessRights Cerrado es_ES
dc.contributor.affiliation Universitat Politècnica de València. Departamento de Ingeniería Electrónica - Departament d'Enginyeria Electrònica es_ES
dc.contributor.affiliation Universitat Politècnica de València. Centro de Biomateriales e Ingeniería Tisular - Centre de Biomaterials i Enginyeria Tissular es_ES
dc.description.bibliographicCitation Husser, O.; Monmeneu Menadas, JV.; Bonanad, C.; Gomez, C.; Chaustre, F.; Nuñez, J.; López Lereu, MP.... (2013). Head-to-head comparison of 1 week versus 6 months CMR-derived infarct size for prediction of late events after STEMI. International Journal of Cardiovascular Imaging. 29(7):1499-1509. https://doi.org/10.1007/s10554-013-0239-1 es_ES
dc.description.accrualMethod S es_ES
dc.relation.publisherversion http://doi.org/10.1007/s10554-013-0239-1 es_ES
dc.description.upvformatpinicio 1499 es_ES
dc.description.upvformatpfin 1509 es_ES
dc.type.version info:eu-repo/semantics/publishedVersion es_ES
dc.description.volume 29 es_ES
dc.description.issue 7 es_ES
dc.relation.senia 253413 es_ES
dc.identifier.eissn 1573-0743
dc.contributor.funder Ministerio de Ciencia e Innovación es_ES
dc.contributor.funder Universität Regensburg es_ES
dc.description.references Perazzolo Marra M, Lima JA, Iliceto S (2011) MRI in acute myocardial infarction. Eur Heart J 32:284–293. doi: 10.1093/eurheartj/ehq409 es_ES
dc.description.references Hombach V, Merkle N, Kestler HA, Torzewski J, Kochs M et al (2008) Characterization of patients with acute chest pain using cardiac magnetic resonance imaging. Clin Res Cardiol 97:760–767 es_ES
dc.description.references Kim RJ, Wu E, Rafael A, Chen EL, Parker MA et al (2000) The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343:1445–1453. doi: 10.1056/NEJM200011163432003 es_ES
dc.description.references Bodí V, Husser O, Sanchis J, Núñez J, López-Lereu MP et al (2010) Contractile reserve and extent of transmural necrosis in the setting of myocardial stunning: comparison at cardiac MR imaging. Radiology 255:755–763. doi: 10.1148/radiol.10091191 es_ES
dc.description.references Bodi V, Sanchis J, Nunez J, Mainar L, Lopez-Lereu MP et al (2009) Prognostic value of a comprehensive cardiac magnetic resonance assessment soon after a first ST-segment elevation myocardial infarction. JACC Cardiovasc Imaging 2:835–842. doi: 10.1016/j.jcmg.2009.03.011 es_ES
dc.description.references Wu KC, Zerhouni EA, Judd RM, Lugo-Olivieri CH, Barouch LA et al (1998) Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 97:765–772 es_ES
dc.description.references Hombach V, Grebe O, Merkle N, Waldenmaier S, Hoher M et al (2005) Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J 26:549–557 es_ES
dc.description.references de Waha S, Desch S, Eitel I, Fuernau G, Lurz P et al (2012) Relationship and prognostic value of microvascular obstruction and infarct size in ST-elevation myocardial infarction as visualized by magnetic resonance imaging. Clin Res Cardiol 101:487–495. doi: 10.1007/s00392-012-0419-3 es_ES
dc.description.references Yan AT, Gibson CM, Larose E, Anavekar NS, Tsang S et al (2006) Characterization of microvascular dysfunction after acute myocardial infarction by cardiovascular magnetic resonance first-pass perfusion and late gadolinium enhancement imaging. J Cardiovasc Magn Reson 8:831–837. doi: 10.1080/10976640600778049 es_ES
dc.description.references Ørn S, Manhenke C, Greve OJ, Larsen AI, Bonarjee VV et al (2009) Microvascular obstruction is a major determinant of infarct healing and subsequent left ventricular remodelling following primary percutaneous coronary intervention. Eur Heart J 30:1978–1985. doi: 10.1093/eurheartj/ehp219 es_ES
dc.description.references Ingkanisorn WP, Rhoads KL, Aletras AH, Kellman P, Arai AE (2004) Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction. J Am Coll Cardiol 43:2253–2259. doi: 10.1016/j.jacc.2004.02.046 es_ES
dc.description.references Fieno DS, Hillenbrand HB, Rehwald WG, Harris KR, Decker RS et al (2004) Infarct resorption, compensatory hypertrophy, and differing patterns of ventricular remodeling following myocardial infarctions of varying size. J Am Coll Cardiol 43:2124–2131. doi: 10.1016/j.jacc.2004.01.043 es_ES
dc.description.references Mewton N, Liu CY, Croisille P, Bluemke D, Lima JA (2011) Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol 57:891–903. doi: 10.1016/j.jacc.2010.11.013 es_ES
dc.description.references van den Borne SW, Diez J, Blankesteijn WM, Verjans J, Hofstra L, Narula J (2010) Myocardial remodeling after infarction: the role of myofibroblasts. Nat Rev Cardiol 7:30–37. doi: 10.1038/nrcardio.2009.199 es_ES
dc.description.references Henriques JP, Zijlstra F, van‘t Hof AW, de Boer MJ, Dambrink JH et al (2003) Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade. Circulation 107:2115–2119. doi: 10.1161/01.CIR.0000065221.06430.ED es_ES
dc.description.references Bodi V, Sanchis J, Lopez-Lereu MP, Nunez J, Mainar L et al (2009) Prognostic and therapeutic implications of dipyridamole stress cardiovascular magnetic resonance on the basis of the ischaemic cascade. Heart 95:49–55. doi: 10.1136/hrt.2007.139683 es_ES
dc.description.references Stehling MK, Holzknecht NG, Laub G, Böhm D, von Smekal A, Reiser M (1996) Single-shot T1- and T2-weighted magnetic resonance imaging of the heart with black blood: preliminary experience. MAGMA 4:231–240 es_ES
dc.description.references Simonetti OP, Finn JP, White RD, Laub G, Henry DA (1996) “Black blood” T2-weighted inversion-recovery MR imaging of the heart. Radiology 199:49–57 es_ES
dc.description.references Abdel-Aty H, Boyé P, Zagrosek A, Wassmuth R, Kumar A et al (2005) Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol 45:1815–1822. doi: 10.1016/j.jacc.2004.11.069 es_ES
dc.description.references Bodi V, Sanchis J, Lopez-Lereu MP, Nunez J, Mainar L et al (2007) Prognostic value of dipyridamole stress cardiovascular magnetic resonance imaging in patients with known or suspected coronary artery disease. J Am Coll Cardiol 50:1174–1179. doi: 10.1016/j.jacc.2007.06.016 es_ES
dc.description.references Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S et al (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105:539–542 es_ES
dc.description.references Husser O, Bodi V, Sanchis J, Nunez J, Lopez-Lereu MP et al (2011) Predictors of cardiovascular magnetic resonance-derived microvascular obstruction on patient admission in STEMI. Int J Cardiol. doi: 10.1016/j.ijcard.2011.09.083 es_ES
dc.description.references Monmeneu JV, Bodi V, Sanchis J, Lopez-Lereu MP, Mainar L et al (2009) Cardiac magnetic resonance evaluation of edema after ST-elevation acute myocardial infarction. Rev Esp Cardiol 62:858–866 es_ES
dc.description.references Thygesen K, Alpert JS, White HD (2007) Universal definition of myocardial infarction. J Am Coll Cardiol 50:2173–2195 es_ES
dc.description.references Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P et al (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29:2388–2442 es_ES
dc.description.references Saeed M, Lund G, Wendland MF, Bremerich J, Weinmann H, Higgins CB (2001) Magnetic resonance characterization of the peri-infarction zone of reperfused myocardial infarction with necrosis-specific and extracellular nonspecific contrast media. Circulation 103:871–876 es_ES
dc.description.references Nadal-Ginard B, Kajstura J, Leri A, Anversa P (2003) Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res 92:139–150 es_ES
dc.description.references Bodi V, Sanchis J, Lopez-Lereu MP, Losada A, Nunez J et al (2005) Usefulness of a comprehensive cardiovascular magnetic resonance imaging assessment for predicting recovery of left ventricular wall motion in the setting of myocardial stunning. J Am Coll Cardiol 46:1747–1752 es_ES
dc.description.references Wu E, Ortiz JT, Tejedor P, Lee DC, Bucciarelli-Ducci C et al (2008) Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study. Heart 94:730–736 es_ES
dc.description.references Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C et al (2012) ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 33:2569–2619. doi: 10.1093/eurheartj/ehs215 es_ES
dc.description.references Wu KC, Kim RJ, Bluemke DA, Rochitte CE, Zerhouni EA et al (1998) Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion. J Am Coll Cardiol 32:1756–1764 es_ES
dc.description.references Eitel I, Kubusch K, Strohm O, Desch S, Mikami Y et al (2011) Prognostic value and determinants of a hypointense infarct core in T2-weighted cardiac magnetic resonance in acute reperfused ST-elevation-myocardial infarction. Circ Cardiovasc Imaging 4:354–362 es_ES
dc.description.references Ganame J, Messalli G, Dymarkowski S, Rademakers FE, Desmet W et al (2009) Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction. Eur Heart J 30:1440–1449 es_ES
dc.description.references Carlsson M, Ubachs JF, Hedström E, Heiberg E, Jovinge S, Arheden H (2009) Myocardium at risk after acute infarction in humans on cardiac magnetic resonance: quantitative assessment during follow-up and validation with single-photon emission computed tomography. JACC Cardiovasc Imaging 2:569–576. doi: 10.1016/j.jcmg.2008.11.018 es_ES


Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem